Derivation and validation of a cardiovascular risk score for prediction of major acute cardiovascular events in non‐alcoholic fatty liver disease; the importance of an elevated mean platelet volume
Alimentary Pharmacology & Therapeutics2019Vol. 49(8), pp. 1077–1085
Citations Over TimeTop 10% of 2019 papers
R.D. Abeles, Benjamin H. Mullish, Roberta Forlano, Torben Kimhofer, Maciej Adler, Alexandros T. Tzallas, Νικόλαος Γιαννακέας, Michael Yee, Jamil Mayet, Robert Goldin, Mark Thursz, Pinelopi Manousou
Abstract
The NAFLD CV risk score and MPV accurately predict 1-year risk of MACE, thereby allowing better identification of patients that require optimisation of their cardiovascular risk profile.
Related Papers
- → Serum IL-38 Level Was Associated with Incidence of MACE in the STEMI Patients(2023)3 cited
- The significance of serum NT-proBNP for the future risk evaluation of major adverse cardiac events in elderly patients with stable coronary artery disease(2013)
- → PM199 Rationale, Design and Feasibility of a Nationwide Prospective Registry of Management of Acute Coronary Events (Mace) in India(2016)
- → Ten-Year Predictors of Major Adverse Cardiovascular Events in Patients without Angina(2022)
- → Ten-year predictors of major adverse cardiovascular events in patients without angina(2023)